SCHEMBL13710200

SCHEMBL13710200

CCNC(=O)OC1=C(c2nc(-c3cccc(C(F)(F)F)c3)sc2C)C(=O)CCC1(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ PPARA Q07869 3/20 0.39
▸ PPARG P37231 2/20 0.39
▸ GRIA2 P42262 1/20 0.38
▸ GRIN1 Q05586 1/20 0.38
▸ GRIN2A Q12879 1/20 0.38
▸ RARA P10276 2/20 0.37
▸ RARB P10826 2/20 0.37
▸ RARG P13631 2/20 0.37
▸ PPARD Q03181 1/20 0.37
▸ DGAT2 Q96PD7 1/20 0.35
▸ KIFC1 Q9BW19 2/20 0.34
▸ RORB Q92753 1/20 0.33
▸ ALPL P05186 1/20 0.33
▸ ALPI P09923 1/20 0.33
▸ CACNA1G O43497 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13761070 0.84 MEN1 (0.44) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL13710201 0.81 ALDH1A1 (0.46) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL13761071 0.68 ALDH1A1 (0.47) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL18003971 0.65 ALDH1A1 (0.58) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL2094451 0.65 ALDH1A1 (0.67) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL14064294 0.64 MAPT (0.41) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL1199183 0.63 ALDH1A1 (0.69) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL12551785 0.63 ADORA2A (0.41) MAPTGRIA2GRIN1GRIN2AALPL
SCHEMBL6229253 0.63 FAAH (0.65) ALDH1A1
SCHEMBL1199289 0.62 ALDH1A1 (0.56) MAPTMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595404-B2 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents BAYER CROPSCIENCE AG (DE) 2009-09-29 — — US disclosed
US-7595404-B2 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents BAYER CROPSCIENCE AG (DE) 2009-09-29 — — US disclosed
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-06-14 — — US disclosed
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents DDT, CYP4B1, CYP1B1 MAPT 4528/4885MEN1 2445/4885KMT2A 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback